What is the official website of ExecuPharm ?

The official website of ExecuPharm is https://http://www.execupharm.com.

What is ExecuPharm's cybersecurity risk score?

ExecuPharm has an AI-generated cybersecurity risk score of 718 out of 1000, indicating a Moderate security posture according to Rankiteo's assessment.

How many security incidents has ExecuPharm experienced?

According to Rankiteo, ExecuPharm currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has ExecuPharm been affected by any supply chain cyber incidents ?

According to Rankiteo, ExecuPharm has been affected by a supply chain cyber incident involving Oracle, with the incident ID ORAPAR1766015901.

Does ExecuPharm have SOC 2 Type 1 certification ?

According to Rankiteo, ExecuPharm is not certified under SOC 2 Type 1.

Does ExecuPharm have SOC 2 Type 2 certification ?

According to Rankiteo, ExecuPharm does not hold a SOC 2 Type 2 certification.

Does ExecuPharm comply with GDPR ?

According to Rankiteo, ExecuPharm is not listed as GDPR compliant.

Does ExecuPharm have PCI DSS certification ?

According to Rankiteo, ExecuPharm does not currently maintain PCI DSS compliance.

Does ExecuPharm comply with HIPAA ?

According to Rankiteo, ExecuPharm is not compliant with HIPAA regulations.

Does ExecuPharm have ISO 27001 certification ?

According to Rankiteo,ExecuPharm is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does ExecuPharm operate in ?

ExecuPharm operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does ExecuPharm have ?

ExecuPharm employs approximately 293 people worldwide.

Does ExecuPharm own any subsidiaries ?

ExecuPharm presently has no subsidiaries across any sectors.

How many LinkedIn followers does ExecuPharm have ?

ExecuPharm's official LinkedIn profile has approximately 42,506 followers.

What is the NAICS classification code for ExecuPharm ?

ExecuPharm is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does ExecuPharm have a Crunchbase profile ?

No, ExecuPharm does not have a profile on Crunchbase.

Does ExecuPharm have a LinkedIn profile ?

Yes, ExecuPharm maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/parexelfsp.

How many cybersecurity incidents has ExecuPharm experienced ?

As of October 5, 2026, Rankiteo reports that ExecuPharm has experienced 2 cybersecurity incidents.

How many peer or competitor companies does ExecuPharm have ?

ExecuPharm has an estimated 5,772 peer or competitor companies worldwide.

What types of cybersecurity incidents has ExecuPharm faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Vulnerability and Ransomware.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

ExecuPharm

Boost Score +25 with badge (5 left)

718

/1000

Moderate

743

/1000

Moderate

ExecuPharm Vendor Cyber Rating & Cyber Score

execupharm.com

Add Your Compliance Badge

ExecuPharm is the North American clinical operations business of Parexel FSP. 10+ years of Experience Meeting Client Needs 10,000+ Global Clinical Operational Specialists In Network 80% of Recruiting Staff with >15 Years of Experience Talent Acquisition, Deployment Rates, and Employee Retention above 90% Management Staff with Tangible Industry Experience Greater Than 95% Repeat Business Average Turnaround Time of 14 Days To Deploy Project Team Resources

ExecuPharm

ExecuPharm CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Parexel

Vulnerability

10/2025

Oracle

ORAPAR176601590...

ExecuPharm

Ransomware

3/2020

EXEPAR176974207...

Loading…

A.I.

ExecuPharm Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for ExecuPharm

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for ExecuPharm in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for ExecuPharm in 2026.

Incident Types ExecuPharm vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for ExecuPharm in 2026.

Incident History - ExecuPharm (X = Date, Y = Severity)

Loading…

SUBSIDIARY

ExecuPharm Subsidiaries

ExecuPharm

Pharmaceutical Manufacturing

Website: https://http://www.execupharm.com

Company Size: 293

ParexelPharmaceutical Manufacturing

Loading…

ExecuPharm Similar Companies

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Fresenius Kabi

fresenius-kabi.com

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Medical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions Imprint: www.fresenius-kabi.com/imprint

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

PT Kalbe Farma, Tbk

kalbe.co.id

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.

Loading…

NEWS

ExecuPharm CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

November 08, 2024 03:28 AM

Cybercriminals Leak ExecuPharm Internal Documents After Ransomware Attack

A successful ransomware attack was deployed on March 13 against ExecuPharm, a subsidiary of the US Biopharmaceutical giant Parexel.

Read Article

August 16, 2024 07:00 AM

Understanding healthcare data breach lawsuit trends

Lawsuits often follow a healthcare data breach, but understanding what drives litigation trends can help healthcare organizations prepare.

Read Article

September 20, 2022 07:00 AM

Data breach, but no identity theft: Can employee still sue?

An important new ruling says an employee can sue her employer even though a data breach did not lead to identity theft or fraud.

Read Article

April 29, 2020 07:00 AM

ExecuPharm, Subsidiary of US Biopharmaceutical Giant Parexel, Hit by Ransomware Attack

ExecuPharm, a subsidiary of the U.S. Biopharmaceutical giant Parexel, has been hit by a ransomware attack according to a recent announcement...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-96451

SUMMARY

Authorization Bypass Through User-Controlled Key vulnerability in Ultimate Member Ultimate Member ultimate-member allows Privilege Escalation.This issue affects Ultimate Member: from n/a through 2.13.1.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://patchstack.com/database/wordpress/plugin/ultimate-member/vulnerability/wordpress-ultimate-member-plugin-2-13-1-privilege-escalation-vulnerability?_s_id=cve

CVE-2026-103342

SUMMARY

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Unlimited Elements Unlimited Elements For Elementor (Free Widgets, Addons, Templates) unlimited-elements-for-elementor allows Reflected XSS.This issue affects Unlimited Elements For Elementor (Free Widgets, Addons, Templates): from n/a through 2.0.20.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L

Impact Score

3.7

Exploitability

2.8

REFERENCES

https://patchstack.com/database/wordpress/plugin/unlimited-elements-for-elementor/vulnerability/wordpress-unlimited-elements-for-elementor-free-widgets-addons-templates-plugin-2-0-20-cross-site-scripting-xss-vulnerability?_s_id=cve

CVE-2026-103065

SUMMARY

Improper Validation of Specified Quantity in Input vulnerability in Themeum Kirki kirki allows Accessing Functionality Not Properly Constrained by ACLs.This issue affects Kirki: from n/a through 6.3.1.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 8.2)

cvss3

Base Score: 8.2

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N

Impact Score

4.2

Exploitability

3.9

REFERENCES

https://patchstack.com/database/wordpress/plugin/kirki/vulnerability/wordpress-kirki-plugin-6-3-1-arbitrary-code-execution-vulnerability?_s_id=cve

CVE-2026-105122

SUMMARY

OpenAM before 16.1.3 contains a server-side request forgery vulnerability that allows attackers able to register or modify OAuth 2.0 clients to make OpenAM fetch internal resources via an unvalidated jwks_uri. Attackers can trigger unauthenticated fetches through client-authentication and ID-token validation to probe internal hosts, metadata endpoints or local files, or exhaust request threads for denial of service.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 5.4)

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:L

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

2.8

REFERENCES

CVE-2026-105121

SUMMARY

OpenAM before 16.1.3 contains an improper authorization vulnerability that allows delegated administrators to destroy sessions outside their realms because realm checks use the requester's realm. Authenticated accounts holding the iplanet-am-session-destroy-sessions attribute can supply a target session identifier or handle to forcibly log out users in any realm.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 4.9)

cvss3

Base Score: 4.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

1.2

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

ExecuPharm Vendor Cyber Rating & Cyber Score

ExecuPharm A.I CyberSecurity Scoring

ExecuPharm CyberSecurity News & History

ExecuPharm Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for ExecuPharm

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types ExecuPharm vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - ExecuPharm (X = Date, Y = Severity)

ExecuPharm Subsidiaries

ExecuPharm

ExecuPharm Similar Companies

Sanofi

Hikma Pharmaceuticals

MACLEODS PHARMACEUTICALS LTD.

Glenmark Pharmaceuticals

Novo Nordisk

Teva Pharmaceuticals

Fresenius Kabi

Torrent Pharmaceuticals Ltd

PT Kalbe Farma, Tbk

ExecuPharm CyberSecurity News

Cybercriminals Leak ExecuPharm Internal Documents After Ransomware Attack

Understanding healthcare data breach lawsuit trends

Data breach, but no identity theft: Can employee still sue?

ExecuPharm, Subsidiary of US Biopharmaceutical Giant Parexel, Hit by Ransomware Attack

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

ExecuPharm CyberSecurity News & History

ExecuPharm Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for ExecuPharm

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types ExecuPharm vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - ExecuPharm (X = Date, Y = Severity)

ExecuPharm Subsidiaries

ExecuPharm

ExecuPharm Similar Companies

Sanofi

Hikma Pharmaceuticals

MACLEODS PHARMACEUTICALS LTD.

Glenmark Pharmaceuticals

Novo Nordisk

Teva Pharmaceuticals

Fresenius Kabi

Torrent Pharmaceuticals Ltd

PT Kalbe Farma, Tbk

ExecuPharm CyberSecurity News

Cybercriminals Leak ExecuPharm Internal Documents After Ransomware Attack

Understanding healthcare data breach lawsuit trends

Data breach, but no identity theft: Can employee still sue?

ExecuPharm, Subsidiary of US Biopharmaceutical Giant Parexel, Hit by Ransomware Attack

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo